Last Seven Days

27 articles from the last seven days

• 
  CSL lowers prices in Trump MFN deal

  CSL and eight other pharmas have signed a Most Favoured Nation deal with the US, with the Aussie giant saying it does not anticipate any 'material impact' during fiscal year 2027

  1 Sep 2026
• 
  $10M for Aussie infectious diseases innovation

  Six Australian companies addressing significant local and global unmet health needs in infectious diseases are getting support to break into commercial success

  1 Sep 2026
• 
  September PBS listings climb to eight

  Six pharmas have expanded their drugs on the PBS this month - including the first biologic added to the scheme for adults with uncontrolled COPD - with two companies scoring a double win

  1 Sep 2026
• 
  Pharma deal to ramp up retail reach in Australia

  New commercial collaboration bringing together 'complementary strengths' of two pharmas is a stepping-stone to further collaboration across a broad pipeline

  1 Sep 2026
• 
  Who has the most effective MSLs, and why?

  A survey of US oncologists has revealed what separates highly effective MSL teams from average ones and without prompting, doctors named the companies that stand out

  1 Sep 2026
• 
  CEO raises red flag on PBS transparency

  Boss warns there is currently no mechanism to disclose a drug’s commercial history citing the example of a treatment originally developed by Big Tobacco

  1 Sep 2026
• 
  Patients choosing between meds or meals

  The Leukaemia Foundation has launched a campaign to improve financial assistance to people diagnosed with blood cancer, so they don't forgo treatment due to lack of funds

  1 Sep 2026